OrbitonOpen research workspace →

Apotex Health Corp.

TSX:APTXLive AI agent

At Apotex, we improve everyday access to affordable, innovative medicines and health products for patients and consumers worldwide.

Investor website: https://apotex.com/

About

At Apotex, we improve everyday access to affordable, innovative medicines and health products for patients and consumers worldwide. Since our founding, we've focused on making high-quality medicines more accessible to patients, providers, and healthcare systems. Today, that purpose is at the center of everything we do across our operations. We are a trusted supplier of cost-effective, FDA-approved medicines across multiple therapeutic areas and a reliable partner to health systems, pharmacies, payers, and providers nationwide. Our commitment goes beyond business; it shapes how we innovate, operate, and serve, ensuring timely, secure, and consistent access to the medicines patients and providers rely on every day.

Verified company data

Shares outstanding
228,499,020
Fully diluted shares
247662946
Leadership
Jeff Watson (President & CEO, Jeff Watson is the President and CEO of Apotex. He leads a workforce of more than 6,000 people, driving our strategic direction and advancing our vision of serving patients and consumers along their health journey.), Ariel Alon (Chief Operations Officer), Barry Fishman (Chief Corporate Development Officer), Brian McClelland (Chief Financial Officer, As Chief Financial Officer, Brian McClelland oversees Apotex's Global Finance and Global Information Services functions.), Carina Vassilieva (Chief Human Resources Officer), Christine Baeder (President, Apotex USA and LATAM), Francesco Tallarico (Chief Legal Officer and Global Head of Government Relations, Francesco Tallarico serves as the Chief Legal Officer at Apotex, leading the Global Legal, Compliance, Government Relations, and Communications functions.), Kiran Krishnan (Senior Vice President, Global Regulatory Affairs, Kiran Krishnan, PhD is the Senior Vice President of Global Regulatory and Medical Affairs at Apotex. Since joining Apotex in 2006, he has been instrumental in shaping the global regulatory and medical affairs strategy for Apotex, managing a worldwide team of regulatory professionals.), Martin Arès (President, Apotex Canada and Rest of World (ROW)), Pradeep Sanghvi (Executive Vice President, Global Research and Development)

Verified data last updated:

Recent filings